- Home
- COEP vs SDST Comparison
COEP vs SDST Comparison
Compare COEP & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- SDST
- Stock Information
- Founded
- COEP 2017
- SDST 2022
- Country
- COEP United States
- SDST United States
- Employees
- COEP N/A
- SDST N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- SDST Blank Checks
- Sector
- COEP Health Care
- SDST Finance
- Exchange
- COEP Nasdaq
- SDST Nasdaq
- Market Cap
- COEP 32.0M
- SDST 33.1M
- IPO Year
- COEP N/A
- SDST N/A
- Fundamental
- Price
- COEP $9.15
- SDST $0.62
- Analyst Decision
- COEP
- SDST Buy
- Analyst Count
- COEP 0
- SDST 2
- Target Price
- COEP N/A
- SDST $1.70
- AVG Volume (30 Days)
- COEP 31.8K
- SDST 959.2K
- Earning Date
- COEP 05-14-2025
- SDST 05-14-2025
- Dividend Yield
- COEP N/A
- SDST N/A
- EPS Growth
- COEP N/A
- SDST N/A
- EPS
- COEP N/A
- SDST N/A
- Revenue
- COEP $62,874.00
- SDST N/A
- Revenue This Year
- COEP N/A
- SDST $4,114.37
- Revenue Next Year
- COEP N/A
- SDST N/A
- P/E Ratio
- COEP N/A
- SDST N/A
- Revenue Growth
- COEP N/A
- SDST N/A
- 52 Week Low
- COEP $2.31
- SDST $0.41
- 52 Week High
- COEP $13.70
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- COEP 46.80
- SDST N/A
- Support Level
- COEP $8.95
- SDST N/A
- Resistance Level
- COEP $9.85
- SDST N/A
- Average True Range (ATR)
- COEP 0.64
- SDST 0.00
- MACD
- COEP -0.02
- SDST 0.00
- Stochastic Oscillator
- COEP 10.47
- SDST 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).